Patients The paradox of cardiovascular disease: Out in the open, but ... When prompted with the question, ’What is the world’s deadliest disease?’, what would be your first guess?
News Lundbeck preps for key bexicaserin data around year-end Lundbeck has completed patient randomisation in a pivotal trial of epilepsy candidate bexicaserin, one of its major growth hopes.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
